JESSICA LEE: Open Payments
NPI 1003461831 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 50 payments from 20 companies in 2025. Trend: 2023 $347 · 2024 $198 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Calliditas Therapeutics US Inc. | 4 | $100 |
| Novo Nordisk Inc | 3 | $78 |
| Lilly USA, LLC | 4 | $72 |
| Amgen Inc. | 3 | $71 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| Madrigal Pharmaceuticals | 3 | $63 |
| Sandoz Inc. | 3 | $53 |
| Exact Sciences Corporation | 2 | $46 |
Products named: JYNARQUE, JARDIANCE, TARPEYO, Fabhalta, TAVNEOS, REZDIFFRA, HYRIMOZ, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
